Any current/future new fundraising through debt or equity?

There is no mention of any current or future plans for fundraising through debt or equity in the transcript. Management indicated that major projects like the AHP project are completed. For FY'24-25, expected capital expenditure is limited to existing capital investments across poultry, AHP, and oil segments totaling around Rs. 40-50 crores. No major new capital projects or fundraising activities are planned or disclosed during the call.

Any current/future capex/capital investment/strategic investment?

No major new capital projects are planned for FY'24-25 as the significant capital expenditure for the Animal Health Products (AHP) expansion has been completed. The new AHP plant became operational in January and will start contributing to production and revenue in the current financial year. Capital expenditure for FY'24-25 is expected to be modest, around Rs. 40-50 crores, covering maintenance and existing units across poultry, AHP, and oil seed segments. There are no announcements of additional or strategic investments beyond ongoing capacity utilization improvements and existing unit maint

Future growth expectations in sales/revenue/volumes?

Poultry division is expected to show positive volume and value growth compared to the last financial year, driven by improving prices and demand (Page 8). Animal Health Product (AHP) division aims to grow its revenue by over 20% in FY'25, supported by capacity expansion and regulatory compliance of new manufacturing units (Page 7). The new AHP plant is futuristic and will help grow volumes steadily over 3-5 years; currently, capacity utilization in the new plant is 35-40%, expected to increase gradually (Pages 13-14). Oil seed division revenues declined from FY'22 but gradual improvement

Future growth expectations in earnings/operating earnings/profits/EPS?

Poultry segment margins are expected to improve in FY'25 due to stable input prices (maize and soya) and better realizations, with growth anticipated from increased volumes and improved industry conditions. Animal Health Product (AHP) division aims to grow revenues by over 20% in FY'25, supported by new capacity coming onstream and regulatory compliance. Oil seed segment margins likely to recover gradually but not back to historical highs due to better crop sowing and market factors; growth depends on poultry segment performance. Overall better performance expected in FY'25 versus FY'24 due to

Venkys (India) LtdQ4 FY24Food Products

Venkys (India) Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,504.3P/E: 12.2Market Cap: ₹2.1K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Poultry division is expected to show positive volume and value growth compared to the last financial year, driven by improving prices and demand (Page 8).
Animal Health Product (AHP) division aims to grow its revenue by over 20% in FY'25, supported by capacity expansion and regulatory compliance of new manufacturing units (Page 7).
The new AHP plant is futuristic and will help grow volumes steadily over 3-5 years; currently, capacity utilization in the new plant is 35-40%, expected to increase gradually (Pages 13-14).
Oil seed division revenues declined from FY'22 but gradual improvement is expected as poultry consumption grows and market conditions normalize; no major revenue growth target disclosed, but consumption-led improvement foreseen (Pages 6-8).
Processed chicken and QSR business is growing, with expansion in franchise outlets and planned marketing expenditures to boost sales (Page 12).
Cross-selling between poultry products and AHP is being leveraged to support growth (Page 13).

Margin guidance

Category 3

Poultry segment margins are expected to improve in FY'25 due to stable input prices (maize and soya) and better realizations, with growth anticipated from increased volumes and improved industry conditions.
Animal Health Product (AHP) division aims to grow revenues by over 20% in FY'25, supported by new capacity coming onstream and regulatory compliance.
Oil seed segment margins likely to recover gradually but not back to historical highs due to better crop sowing and market factors; growth depends on poultry segment performance.
Overall better performance expected in FY'25 versus FY'24 due to improved poultry prices and operational efficiency.
The company is focusing on growth through capacity utilization improvements, new product development, and franchise expansion in the processed food (QSR) segment.
Management expects quarterly concalls for better investor insights, reflecting confidence in steady progress.

See what Venkys (India) Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or future plans for fundraising through debt or equity in the transcript.
Management indicated that major projects like the AHP project are completed.
For FY'24-25, expected capital expenditure is limited to existing capital investments across poultry, AHP, and oil segments totaling around Rs. 40-50 crores.
No major new capital projects or fundraising activities are planned or disclosed during the call.

Order book

The provided transcript of Venky's Limited conference call dated May 13, 2024, does not contain any specific information or data regarding the current or expected order book or pending orders for the company. The discussion primarily covers topics like balance sheet items, financial performance, segment-wise revenue, commodity prices, capacity utilization, and future outlook for different business segments. There are no mentions or disclosures about outstanding orders or order backlog in the transcript.

See what Venkys (India) Ltd management said on order book — free account, 30 seconds.

Capex plans

No major new capital projects are planned for FY'24-25 as the significant capital expenditure for the Animal Health Products (AHP) expansion has been completed.
The new AHP plant became operational in January and will start contributing to production and revenue in the current financial year.
Capital expenditure for FY'24-25 is expected to be modest, around Rs. 40-50 crores, covering maintenance and existing units across poultry, AHP, and oil seed segments.
There are no announcements of additional or strategic investments beyond ongoing capacity utilization improvements and existing unit maintenance.

Track Venkys (India) Ltd — get its next earnings analysis in your feed

How does Venkys (India) Ltd rank vs peers in Food Products?

Pro feature

ThisVenkys (India) Ltd

Rev 3Mar 3

See where Venkys (India) Ltd sits in Food ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Venkys (India) Ltd rank in Food Products?

Compare Venkys (India) Ltd against every Food Products company (Q4 FY24) on revenue, margins and earnings-call signals.

View Food Products leaderboard →

What Venkys (India) Ltd's management said in earlier quarters

Others in Food Products this season

Prataap Snacks Ltd (Q2 FY27)
Q2 FY27 income from operations was ₹540.95 crore, a 25.9% increase year-on-year (YoY). Key results statement takeaways from Prataap Snacks Ltd's Q2 FY27 results
Madhusudan Masa (Q2 FY27)
4,158.28 lakh (Q2 2025), approximately +118% YoY. Key results statement takeaways from Madhusudan Masala Ltd's Q2 FY27 results statement — and how it ranks agai
Vadilal Industries Ltd (Q2 FY27)
Revenue from operations for the quarter ended September 30, 2026: ₹462.56 crore (Consolidated, Page 11) . Key results statement takeaways from Vadilal Industrie
Wardwizard Foods & Beverages Ltd (Q1 FY27)
Revenue for Q1 FY27 (June 2026 quarter) is ₹17.03 Cr, up from ₹13.20 Cr in Q1 FY26, reflecting a strong year-on-year growth. Key investor presentation takeaways

Compare:vs Nestle India vs Britannia Inds.vs Milky Mist Dairy Food Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Venkys (India) Ltd Q4 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Venkys (India) Ltd rank in Food Products?

Continue your research

What Venkys (India) Ltd's management said in earlier quarters

Others in Food Products this season